Agios Pharmaceuticals Inc Forward P/E
What is the Forward P/E of Agios Pharmaceuticals Inc?
The Forward P/E of Agios Pharmaceuticals Inc is -3.82
What is the definition of Forward P/E?
Forward price to earnings ratio is the ratio of a company’s stock price to the company’s estimated earnings per share for the next twelve months.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Forward P/E of companies in the Health Care sector on NASDAQ compared to Agios Pharmaceuticals Inc
What does Agios Pharmaceuticals Inc do?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Companies with forward p/e similar to Agios Pharmaceuticals Inc
- Peloton Interactive Inc has Forward P/E of -3.88
- aap Implantate AG has Forward P/E of -3.84
- Pharnext SA has Forward P/E of -3.84
- Tinka Resources has Forward P/E of -3.83
- Trilogy International Partners has Forward P/E of -3.82
- Midas Gold has Forward P/E of -3.82
- Agios Pharmaceuticals Inc has Forward P/E of -3.82
- Recon Technology Ltd has Forward P/E of -3.80
- Ballard Power Systems has Forward P/E of -3.79
- comScore has Forward P/E of -3.78
- Avenue Therapeutics Inc has Forward P/E of -3.74
- Compugen Ltd has Forward P/E of -3.73
- Vir Biotechnology Inc has Forward P/E of -3.70